ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,679.88
-0.03%
Dow Jones
42,701.14
0.29%
Gold vs US Dollar
2,904.09
-0.23%
Brent Oil
70.155
1.18%
Bitcoin
88,404.29
-1.70%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Assembly Biosciences Inc (ASMB) Share Price

ASMB Assembly Biosciences Inc

11.27
-0.16 (-1.40%)
Last Updated: 18:15:54
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Assembly Biosciences Inc NASDAQ:ASMB NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.16 -1.40 11.27 11.40 11.59 11.90 10.89 11.5 18,436 18:15:54   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 7.16M -61.23M -9.6327 -1.15 72.65M
 Type  Size  Price  Time  Units 
 9 47 11.2751 18:14:21 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ASMB News
26/02/202513:00GLOBEAssembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
20/02/202521:05EDGAR2Form 8-K - Current report
20/02/202513:00GLOBEAssembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes
14/02/202521:58EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
31/12/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
26/12/202413:25EDGAR2Form 8-K - Current report
26/12/202413:00GLOBEAssembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
Period
Draw mode
Data Downloads for ASMB

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Your Recent History

NASDAQ
ASMB
Assembly Biosciences
AMEX
BITO
ProShares Bitcoin ETF
BOV
MRFG3T
MARFRIG
BOV
MATD3F
Hospital Mater Dei S.A ON
BOV
TELM11
Tellus Multiest Fdo Inv ...
BIT
F28832
Vontobel Financial Produ...
BIT
Q00288
Leonteq Securities
BIT
S28199
Societe Generale Effekten
BIT
S29306
Societe Generale Effekten
BIT
I08963
Intesa Sanpaolo
BIT
ECK
Ecosuntek
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads